-
Jessica Kenney will be leaving MSK to pursue a career in Research and Education as an Operational Development Specialist, at Columbia University. Herlast full day in the Molecular Epidemiology Lab will be Friday December 6th, 2024.
Jess joined our Department and the Molecular Epidemiology Laboratory in March of 2018, to dive in – among other activities- into a study of predictors and impact of post-diagnosis smoking in bladder cancer led by Helena Furberg in which she biochemically confirmed use or exposure to tobacco smoke/products. She was key to the success of the multi-center melanoma program project InterMEL – by receiving tissues and procuring characterized nucleic acids for all the downstream testing. She also contributed to the biocollections for glioma and breast cancer studies led by Jonine Bernstein, the ‘The Learning and Coping with Breast Cancer’ study led by Tim Ahles and the CASTL study led by Jamie Ostroff. In addition, Jess helped set up new immunoassays applied to pilot studies that helped secure NIH-funding for the ‘Prospective metabolomics investigation of gastric cancer risk in African Americans and European Whites with a low socioeconomic status’ (Xiang Shu, PI), and the ‘Effect and Mechanism of Acupuncture for Cancer‑related Cognitive Impairment’ (Jun Mao, PI). She is currently contributing to the ‘Genetic susceptibility to Barrett’s esophagus: from GWAS to biology’ study led by Matt Buas. Jess is pursuing an MBA in healthcare which she anticipates to complete in 2025.
Please join us in thanking Jess for all her contributions to our Research Program and wishing her much success in the new position. -
Gbemisola “Liz” Ilelaboye has moved on to a teaching position at Seton Hall University. We miss her kindness and contagious joy but are happy for her professional growth. Her students are very lucky as Liz is a wonderful teacher.At MSK, some of her salient laboratory research involved the large international pathoepidemiologic melanoma studies in collaboration with the InterMEL & the Genes, Environment and Melanoma (GEM) consortia. She is also key to the genetics assay design for the Study “Genetic susceptibility to cancer related cognitive dysfunction in women undergoing treatment for breast cancer”.With warm regards,
Irene & the Molecular Epi Lab mates & friends - Construction of the New Lab has been completed and we’ve moved back from our interim residence space at LMB (327 East 64th Street, Rm 411) to Main Campus, Schwartz S10: S-1033 (Main Lab) and S-1028 (sample entry/initial processing). Go to the ‘Get in Touch’ section for our new phone numbers.To allow us to continue processing and testing quality biospecimens, and producing meaningful data, please stay in touch regarding potential or confirmed incoming participants’ samples collected under the IRB protocols listed below.Studies with active accrual and biospecimens collection:#02-102 (‘PAN’)#10-079 (‘TLC’)#17-007 (‘InterMEL’)#17-500 (‘CASTL’)#18-240 (‘Leverage’)#20-124 (‘ENHANCE’)
-
As usual, to allow us to process and test quality biospecimens, and produce meaningful data, stay in touch regarding potential or confirmed incoming participants’ samples collected under the IRB protocols listed below. Studies with active accrual and biospecimens collection:
- #02-102 (‘PAN’)
- #10-079 (‘TLC’)
- #17-007 (‘InterMEL’)
- #17-500 (‘CASTL’)
- #18-240 (‘Leverage’)
- #20-124 (‘ENHANCE’)
- Incoming Spring & Summer 2024!We look forward working with Dr. David Millán Esteban - a Research Fellow visiting us from April until end of August; and welcoming back our wonderful Summer Intern, Sophia D.